Report Library
View More
Datamonitor Healthcare Oncology: Th...
January 21, 2022
Datamonitor Healthcare I&I: Acne Ma...
January 21, 2022
Datamonitor Healthcare Other: Polyc...
January 20, 2022
Datamonitor Healthcare I&I: Heredit...
January 20, 2022
Datamonitor Healthcare I&I: Celiac ...
January 20, 2022
Datamonitor Healthcare CNS Disease ...
January 19, 2022
Datamonitor Healthcare Respiratory ...
January 18, 2022
Datamonitor Healthcare Oncology Dis...
January 18, 2022
Datamonitor Healthcare Oncology Dis...
January 17, 2022
Datamonitor Healthcare Oncology Dis...
January 13, 2022
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 1/21/22 | UCB (UCB) | Bimekizumab for Psoriatic Arthritis (PA) | Subscribers Only | Subscribers Only | Subscribers Only |
| 1/19/22 | Sanofi (SNY) | Dupixent for Pruritus | Subscribers Only | Subscribers Only | Subscribers Only |
| 1/18/22 | AstraZeneca (AZN) | Imfinzi for Hepatocellular (Liver) Cancer (HCC) (Including Secondary Metastases) | Subscribers Only | Subscribers Only | Subscribers Only |
| 1/18/22 | ImmunityBio (IBRX) | Anktiva for Pancreatic Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 1/18/22 | Exelixis (EXEL) | Cabometyx / Cometriq for Colorectal Cancer (CRC) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 01/22/22 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 01/22/22 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 01/24/22 | Subscribers Only | Subscribers Only | Regulatory - Meeting with FDA |
| 01/25/22 | Subscribers Only | Subscribers Only | Patent - Expiration |
| 01/25/22 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
